| MIGROBEN NOVARTIS AG
1287513 26 Jan 2006 | on 15 Feb 2012 | Class 001 Class 001 Chemical Products Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and/or treatment of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and/or treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, erectile dysfunction; pharmaceutical preparations for the prevention and/or treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely, blood and blood forming organs; pharmaceutical preparations for the prevention and/or treatment of disorders of the immune system relating to transplantation; pharmaceutical preparations for use in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines; diagnostic preparations for clinical or medical laboratory use. Class 005 Class 005 Pharmaceutical Products | | | MIGROBEN NOVARTIS AG
1130425 07 Feb 2002 | on 08 Mar 2006 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes. | | 
